Recombinant Meningococcal group B vaccine (Chengdu Kanghua Biological)

重组B群脑膜炎球菌疫苗（康华生物）

Report date: 2025/10/14 14:37:46

Base Information

Drug NameRecombinant Meningococcal group B vaccine (Chengdu Kanghua Biological)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Kanghua Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Kanghua Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A